Affiliation:
1. Department of Neurology, Brigham and Women’s Hospital,
2. Program in Neuroscience, Harvard Medical School, Boston, MA 02115, United States of America
Abstract
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson’s disease (PD), which is the leading neurodegenerative movement disorder characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). However, whether LRRK2 mutations cause PD and degeneration of DA neurons
via
a toxic gain-of-function or a loss-of-function mechanism is unresolved and has pivotal implications for LRRK2-based PD therapies. In this study, we investigate whether LRRK2 and its functional homologue LRRK1 play an essential, intrinsic role in DA neuron survival through the development of DA neuron-specific
LRRK
conditional double knockout (cDKO) mice. We first generated and characterized floxed
LRRK1
and
LRRK2
mice and then confirmed that germline deletions of the floxed
LRRK1
and
LRRK2
alleles result in null mutations, as evidenced by the absence of
LRRK1
and
LRRK2
mRNA and protein in the respective homozygous deleted mutant mice. We further examined the specificity of Cre-mediated recombination driven by the
dopamine transporter
-
Cre
(
DAT-Cre
) knockin (KI) allele using a GFP reporter line and confirmed that
DAT-Cre
-mediated recombination is restricted to DA neurons in the SNpc. Crossing these validated floxed
LRRK1
and
LRRK2
mice with
DAT-Cre
KI mice, we then generated DA neuron-restricted
LRRK
cDKO mice and further showed that levels of LRRK1 and LRRK2 are reduced in dissected ventral midbrains of
LRRK
cDKO mice. While DA neuron-restricted
LRRK
cDKO mice of both sexes exhibit normal mortality and body weight, they develop age-dependent loss of DA neurons in the SNpc, as demonstrated by the progressive reduction of DA neurons in the SNpc of
LRRK
cDKO mice at the ages of 20 and 24 months but the unaffected number of DA neurons at the age of 15 months. Moreover, DA neurodegeneration is accompanied with increases of apoptosis and elevated microgliosis in the SNpc as well as decreases of DA terminals in the striatum, and is preceded by impaired motor coordination. Taken together, these findings provide the unequivocal evidence for the importance of LRRK in DA neurons and raise the possibility that LRRK2 mutations may impair its protection of DA neurons, leading to DA neurodegeneration in PD.
Publisher
eLife Sciences Publications, Ltd